Gilead

Gilead is a biopharmaceutical company that researches, develops, and sells drugs for various diseases, including those in the fields of HIV, oncology, and immunology.

Why it’s in the news: It is in the news due to a recent legal victory at the California Supreme Court regarding its 'duty to innovate' and ongoing discussions about its business strategy and setbacks.

Latest on Gilead

• STAT+: Why Gilead can’t stop talking about its ambitions in immunology
• STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
• STAT+: Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more
• STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
• STAT+: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more
• STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents

Connections

5 entities linked to Gilead across the news graph.